Drug intelligence / Profile preview

Cook-Waite Lidocaine HCl and Epinephrine

Development stage
Unknown
Lead developer
Cook-Waite Laboratories
Modality
Small Molecules
Administration
Injection
01

Overview

Cook-Waite Lidocaine with Epinephrine is an FDA-approved local anesthetic combination product marketed by Septodont under the Cook-Waite brand for dental pain management. The formulation contains lidocaine hydrochloride 2% as the active anesthetic agent combined with epinephrine (available in concentrations of 1:50,000 or 1:100,000) as a vasoconstrictor. Lidocaine works by blocking voltage-gated sodium channels to inhibit nerve conduction, while epinephrine acts on adrenergic receptors to produce local vasoconstriction, which prolongs the anesthetic effect and improves hemostasis. This small molecule combination is administered via injectable cartridges for local infiltration or nerve block techniques in routine dental procedures. The product provides rapid onset of anesthesia with a duration of approximately 60 to 90 minutes depending on the technique used.

Brand names
Cook-Waite Lidocaine HCl 2% and Epinephrine 1:100,000Cook-Waite Lidocaine HCl 2% and Epinephrine 1:50,000
Other names
Lidocaine 2% with epinephrine 1:50,000Lidocaine 2% with epinephrine 1:100,000Cook-Waite Lidocaine
02

Targets

NaV (Voltage-gated sodium channels)ADRB1 (β1)ADRA1A (α1A)

Beyond the preview

Go deeper on Cook-Waite Lidocaine HCl and Epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cook-Waite Lidocaine HCl and Epinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call